Versant Venture Management, LLC Portfolio Holdings
Versant Venture Management, LLC
- $71.7 Million
- Q1 2024
Versant Venture Management, LLC has filed its 13F form on May 03, 2024 for Q1 2024 where it was disclosed a total value porftolio of $71.7 Million distributed in 7 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Crispr Therapeutics Ag with a value of $34M, Repare Therapeutics Inc. with a value of $12.5M, Gritstone Bio, Inc. with a value of $9.15M, Adverum Biotechnologies, Inc. with a value of $7.17M, and Passage Bio, Inc. with a value of $6.7M.
Examining the 13F form we can see an increase of $3.6M in the current position value, from $68.1M to 71.7M.
Versant Venture Management, LLC is based out at San Francisco, CA
Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.